Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis

In 27 patients with a first episode of herpes simplex virus type 2 (HSV-2)-induced meningitis, confirmed by virus isolation from the cerebrospinal fluid (CSF) or seroconversion to HSV-2, initial neurologic complications were found in 10 (37%) but subsided before 6 months in all patients. Long-term c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1990-08, Vol.162 (2), p.322-330
Hauptverfasser: Bergström, Tomas, Vahlne, Anders, lestig, Kjell, Jeansson, Stig, Forsgren, Marianne, Lycke, Erik
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 330
container_issue 2
container_start_page 322
container_title The Journal of infectious diseases
container_volume 162
creator Bergström, Tomas
Vahlne, Anders
lestig, Kjell
Jeansson, Stig
Forsgren, Marianne
Lycke, Erik
description In 27 patients with a first episode of herpes simplex virus type 2 (HSV-2)-induced meningitis, confirmed by virus isolation from the cerebrospinal fluid (CSF) or seroconversion to HSV-2, initial neurologic complications were found in 10 (37%) but subsided before 6 months in all patients. Long-term complications were recurrent meningitis in 5 (19%) and periodic headache related to genital HSV recrudescences in 4 (15%). Seven additional patients had possible HSV2- induced recurrent meningitis. In contrast to the first episode of meningitis, virus isolation, HSV antigen detection, and IgG analyses in consecutive serum samples were of no diagnostic value in episodes of HSV-2-induced recurrent meningitis. Instead, immunoblotting was used to assay intrathecally produced IgG antibodies to the HSV-2 type-specific protein gG-2 in recurrent meningitis, when CSF was collected at a minimum of 3 days after onset.
doi_str_mv 10.1093/infdis/162.2.322
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_79893787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30123092</jstor_id><sourcerecordid>30123092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-907eca9f62eb0f60bec149f291c7d3454ae87d1ebaa9c7fc280797a57272e7e53</originalsourceid><addsrcrecordid>eNqFkM9P3DAQhS1UBFvKvRekHKrestjjOGMfK1pYJKCo5Zd6sbzOBBmy2dROJPjvmzbbVW89zeF770nzMfZe8LngRh6Htq5COhYlzGEuAXbYTCiJeVkK-YbNOAfIhTZmn71N6YlzXsgS99geiFIJrmbs83UMKxdfM9dW2TfyQ4zU9tmCYkcp-x5WXUMv2V2IQ8puXjvKID9vq8FTlV1SG9rH0If0ju3Wrkl0uLkH7Pb0y83JIr_4enZ-8uki94Uo-txwJO9MXQIteV3yJXlRmBqM8FjJQhWONFaCls4Zj7UHzdGgUwgIhKTkAfs47XZx_XOg1NtVSJ6axrW0HpJFo41Ejf8NCqW1kFqPQT4FfVynFKm23eTDCm5_G7aTYTsatmBHw2PlaLM9LFdUbQsbpSP_sOEuedfU0bV-HPgbUwrGr_6ZeUr9Om6x5AIk_8PziYfU08uWu_hsS5So7OLhh8Xi-ur-7ArsqfwFPW6c9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15881388</pqid></control><display><type>article</type><title>Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Bergström, Tomas ; Vahlne, Anders ; lestig, Kjell ; Jeansson, Stig ; Forsgren, Marianne ; Lycke, Erik</creator><creatorcontrib>Bergström, Tomas ; Vahlne, Anders ; lestig, Kjell ; Jeansson, Stig ; Forsgren, Marianne ; Lycke, Erik</creatorcontrib><description>In 27 patients with a first episode of herpes simplex virus type 2 (HSV-2)-induced meningitis, confirmed by virus isolation from the cerebrospinal fluid (CSF) or seroconversion to HSV-2, initial neurologic complications were found in 10 (37%) but subsided before 6 months in all patients. Long-term complications were recurrent meningitis in 5 (19%) and periodic headache related to genital HSV recrudescences in 4 (15%). Seven additional patients had possible HSV2- induced recurrent meningitis. In contrast to the first episode of meningitis, virus isolation, HSV antigen detection, and IgG analyses in consecutive serum samples were of no diagnostic value in episodes of HSV-2-induced recurrent meningitis. Instead, immunoblotting was used to assay intrathecally produced IgG antibodies to the HSV-2 type-specific protein gG-2 in recurrent meningitis, when CSF was collected at a minimum of 3 days after onset.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/162.2.322</identifier><identifier>PMID: 2165105</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Antibodies ; Antibodies, Viral - analysis ; Antigens ; Biological and medical sciences ; Cerebrospinal Fluid - cytology ; Cerebrospinal Fluid - microbiology ; Enzyme linked immunosorbent assay ; Female ; Genitalia ; Herpes Simplex - cerebrospinal fluid ; Herpes Simplex - complications ; Herpes Simplex - immunology ; Human herpesvirus 2 ; Humans ; Immunoglobulin G - analysis ; Infections ; Infectious diseases ; Lesions ; Major Articles ; Male ; Medical sciences ; Meningitis, Viral - cerebrospinal fluid ; Meningitis, Viral - complications ; Meningitis, Viral - immunology ; Middle Aged ; Nervous System Diseases - etiology ; Recurrence ; Simplexvirus ; Simplexvirus - immunology ; Simplexvirus - isolation &amp; purification ; Viral diseases ; Viral meningitis ; Viruses</subject><ispartof>The Journal of infectious diseases, 1990-08, Vol.162 (2), p.322-330</ispartof><rights>Copyright 1990 The University of Chicago</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-907eca9f62eb0f60bec149f291c7d3454ae87d1ebaa9c7fc280797a57272e7e53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30123092$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30123092$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27923,27924,58016,58249</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5520792$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2165105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bergström, Tomas</creatorcontrib><creatorcontrib>Vahlne, Anders</creatorcontrib><creatorcontrib>lestig, Kjell</creatorcontrib><creatorcontrib>Jeansson, Stig</creatorcontrib><creatorcontrib>Forsgren, Marianne</creatorcontrib><creatorcontrib>Lycke, Erik</creatorcontrib><title>Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>In 27 patients with a first episode of herpes simplex virus type 2 (HSV-2)-induced meningitis, confirmed by virus isolation from the cerebrospinal fluid (CSF) or seroconversion to HSV-2, initial neurologic complications were found in 10 (37%) but subsided before 6 months in all patients. Long-term complications were recurrent meningitis in 5 (19%) and periodic headache related to genital HSV recrudescences in 4 (15%). Seven additional patients had possible HSV2- induced recurrent meningitis. In contrast to the first episode of meningitis, virus isolation, HSV antigen detection, and IgG analyses in consecutive serum samples were of no diagnostic value in episodes of HSV-2-induced recurrent meningitis. Instead, immunoblotting was used to assay intrathecally produced IgG antibodies to the HSV-2 type-specific protein gG-2 in recurrent meningitis, when CSF was collected at a minimum of 3 days after onset.</description><subject>Antibodies</subject><subject>Antibodies, Viral - analysis</subject><subject>Antigens</subject><subject>Biological and medical sciences</subject><subject>Cerebrospinal Fluid - cytology</subject><subject>Cerebrospinal Fluid - microbiology</subject><subject>Enzyme linked immunosorbent assay</subject><subject>Female</subject><subject>Genitalia</subject><subject>Herpes Simplex - cerebrospinal fluid</subject><subject>Herpes Simplex - complications</subject><subject>Herpes Simplex - immunology</subject><subject>Human herpesvirus 2</subject><subject>Humans</subject><subject>Immunoglobulin G - analysis</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Lesions</subject><subject>Major Articles</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Meningitis, Viral - cerebrospinal fluid</subject><subject>Meningitis, Viral - complications</subject><subject>Meningitis, Viral - immunology</subject><subject>Middle Aged</subject><subject>Nervous System Diseases - etiology</subject><subject>Recurrence</subject><subject>Simplexvirus</subject><subject>Simplexvirus - immunology</subject><subject>Simplexvirus - isolation &amp; purification</subject><subject>Viral diseases</subject><subject>Viral meningitis</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM9P3DAQhS1UBFvKvRekHKrestjjOGMfK1pYJKCo5Zd6sbzOBBmy2dROJPjvmzbbVW89zeF770nzMfZe8LngRh6Htq5COhYlzGEuAXbYTCiJeVkK-YbNOAfIhTZmn71N6YlzXsgS99geiFIJrmbs83UMKxdfM9dW2TfyQ4zU9tmCYkcp-x5WXUMv2V2IQ8puXjvKID9vq8FTlV1SG9rH0If0ju3Wrkl0uLkH7Pb0y83JIr_4enZ-8uki94Uo-txwJO9MXQIteV3yJXlRmBqM8FjJQhWONFaCls4Zj7UHzdGgUwgIhKTkAfs47XZx_XOg1NtVSJ6axrW0HpJFo41Ejf8NCqW1kFqPQT4FfVynFKm23eTDCm5_G7aTYTsatmBHw2PlaLM9LFdUbQsbpSP_sOEuedfU0bV-HPgbUwrGr_6ZeUr9Om6x5AIk_8PziYfU08uWu_hsS5So7OLhh8Xi-ur-7ArsqfwFPW6c9g</recordid><startdate>19900801</startdate><enddate>19900801</enddate><creator>Bergström, Tomas</creator><creator>Vahlne, Anders</creator><creator>lestig, Kjell</creator><creator>Jeansson, Stig</creator><creator>Forsgren, Marianne</creator><creator>Lycke, Erik</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19900801</creationdate><title>Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis</title><author>Bergström, Tomas ; Vahlne, Anders ; lestig, Kjell ; Jeansson, Stig ; Forsgren, Marianne ; Lycke, Erik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-907eca9f62eb0f60bec149f291c7d3454ae87d1ebaa9c7fc280797a57272e7e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Antibodies</topic><topic>Antibodies, Viral - analysis</topic><topic>Antigens</topic><topic>Biological and medical sciences</topic><topic>Cerebrospinal Fluid - cytology</topic><topic>Cerebrospinal Fluid - microbiology</topic><topic>Enzyme linked immunosorbent assay</topic><topic>Female</topic><topic>Genitalia</topic><topic>Herpes Simplex - cerebrospinal fluid</topic><topic>Herpes Simplex - complications</topic><topic>Herpes Simplex - immunology</topic><topic>Human herpesvirus 2</topic><topic>Humans</topic><topic>Immunoglobulin G - analysis</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Lesions</topic><topic>Major Articles</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Meningitis, Viral - cerebrospinal fluid</topic><topic>Meningitis, Viral - complications</topic><topic>Meningitis, Viral - immunology</topic><topic>Middle Aged</topic><topic>Nervous System Diseases - etiology</topic><topic>Recurrence</topic><topic>Simplexvirus</topic><topic>Simplexvirus - immunology</topic><topic>Simplexvirus - isolation &amp; purification</topic><topic>Viral diseases</topic><topic>Viral meningitis</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bergström, Tomas</creatorcontrib><creatorcontrib>Vahlne, Anders</creatorcontrib><creatorcontrib>lestig, Kjell</creatorcontrib><creatorcontrib>Jeansson, Stig</creatorcontrib><creatorcontrib>Forsgren, Marianne</creatorcontrib><creatorcontrib>Lycke, Erik</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bergström, Tomas</au><au>Vahlne, Anders</au><au>lestig, Kjell</au><au>Jeansson, Stig</au><au>Forsgren, Marianne</au><au>Lycke, Erik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1990-08-01</date><risdate>1990</risdate><volume>162</volume><issue>2</issue><spage>322</spage><epage>330</epage><pages>322-330</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>In 27 patients with a first episode of herpes simplex virus type 2 (HSV-2)-induced meningitis, confirmed by virus isolation from the cerebrospinal fluid (CSF) or seroconversion to HSV-2, initial neurologic complications were found in 10 (37%) but subsided before 6 months in all patients. Long-term complications were recurrent meningitis in 5 (19%) and periodic headache related to genital HSV recrudescences in 4 (15%). Seven additional patients had possible HSV2- induced recurrent meningitis. In contrast to the first episode of meningitis, virus isolation, HSV antigen detection, and IgG analyses in consecutive serum samples were of no diagnostic value in episodes of HSV-2-induced recurrent meningitis. Instead, immunoblotting was used to assay intrathecally produced IgG antibodies to the HSV-2 type-specific protein gG-2 in recurrent meningitis, when CSF was collected at a minimum of 3 days after onset.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>2165105</pmid><doi>10.1093/infdis/162.2.322</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1990-08, Vol.162 (2), p.322-330
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_79893787
source MEDLINE; JSTOR Archive Collection A-Z Listing
subjects Antibodies
Antibodies, Viral - analysis
Antigens
Biological and medical sciences
Cerebrospinal Fluid - cytology
Cerebrospinal Fluid - microbiology
Enzyme linked immunosorbent assay
Female
Genitalia
Herpes Simplex - cerebrospinal fluid
Herpes Simplex - complications
Herpes Simplex - immunology
Human herpesvirus 2
Humans
Immunoglobulin G - analysis
Infections
Infectious diseases
Lesions
Major Articles
Male
Medical sciences
Meningitis, Viral - cerebrospinal fluid
Meningitis, Viral - complications
Meningitis, Viral - immunology
Middle Aged
Nervous System Diseases - etiology
Recurrence
Simplexvirus
Simplexvirus - immunology
Simplexvirus - isolation & purification
Viral diseases
Viral meningitis
Viruses
title Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A15%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20and%20Recurrent%20Herpes%20Simplex%20Virus%20Type%202-Induced%20Meningitis&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Bergstr%C3%B6m,%20Tomas&rft.date=1990-08-01&rft.volume=162&rft.issue=2&rft.spage=322&rft.epage=330&rft.pages=322-330&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/162.2.322&rft_dat=%3Cjstor_proqu%3E30123092%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15881388&rft_id=info:pmid/2165105&rft_jstor_id=30123092&rfr_iscdi=true